This result may be a key to understanding the benefit of DPP4 inhibitors in a previous study showing that concurrent use of ACE inhibitors and DPP-4 inhibitors in subjects with metabolic syndrome had a synergistic effect on ACE activity reduction (50). This evidence concerns the gene ACE and metabolic syndrome.